Toll-like receptor ligation for the induction of regulatory B cells

Methods in Molecular Biology

Volumn 1190, Issue , 2014, Pages 127-141

  Van Der Vlugt, Luciën E P M ^a   Haeberlein, Simone ^a   De Graaf, Wouter ^a   Martha, Tyrill E D ^a   Smits, Hermelijn H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human; IL 10; IL 6; Mouse; Regulatory B cells; Toll like receptors

Indexed keywords

INTERLEUKIN 10; TOLL LIKE RECEPTOR; CD19 ANTIGEN; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; CELL SEPARATION; COCULTURE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INNATE IMMUNITY; PROCEDURES; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES, REGULATORY; CELL SEPARATION; COCULTURE TECHNIQUES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; MICE; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 84924085021     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1161-5_10     Document Type: Article

References (48)

1. Fillatreau S, Sweenie CH, McGeachy MJ et al (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944-950
2. Mauri C, Ehrenstein MR (2008) The 'short' history of regulatory B cells. Trends Immunol 29:34-40
3. Blair PA, Chavez-Rueda KA, Evans JG et al (2009) Selective targeting of B cells with agonistic anti-CD40 is an effi cacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 182:3492-3502
4. Kala M, Rhodes SN, Piao WH et al (2010) B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol 221:136-145
5. Lampropoulou V, Calderon-Gomez E, Roch T et al (2010) Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev 233:146-161
6. Yang M, Sun L, Wang S et al (2010) Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184:3321-3325
7. Yehudai D, Snir A, Peri R et al (2012) B cellactivating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand J Immunol 76: 371-377
8. Neves P, Lampropoulou V, Calderon-Gomez E et al (2010) Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33:777-790
9. Sayi A, Kohler E, Toller IM et al (2011) TLR-2-activated B cells suppress Helicobacterinduced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 186:878-890
10. Barr TA, Brown S, Ryan G et al (2007) TLRmediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37:3040-3053
11. Bouaziz JD, Calbo S, Maho-Vaillant M et al (2010) IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40:2686-2691
12. Tian J, Zekzer D, Hanssen L et al (2001) Lipopolysaccharide-activated B cells downregulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167:1081-1089
13. Palanivel V, Posey C, Horauf AM et al (1996) B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 84:168-177
14. Ronet C, Hauyon-La TY, Revaz-Breton M et al (2010) Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 184: 886-894
15. Velupillai P, Harn DA (1994) Oligosaccharidespecific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 91: 18-22
16. Lenert P, Brummel R, Field EH et al (2005) TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 25:29-40
17. Miyazaki D, Kuo CH, Tominaga T et al (2009) Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci 50:1626-1635
18. Noh J, Lee JH, Noh G et al (2010) Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy. Cell Immunol 264:143-149
19. Blair PA, Norena LY, Flores-Borja F et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemiclupus Erythematosus patients. Immunity 32: 129-140
20. Iwata Y, Matsushita T, Horikawa M et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541
21. Flores-Borja F, Bosma A, Ng D et al (2013) CD19 + CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5:173ra23
22. van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A et al (2012) Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 7:e30883
23. van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A et al (2014) CD24 hi CD27 + B cells from allergic asthma patients have impaired regulatory activity in response to LPS. Clin Exp Allergy 44(4):517-528
24. Hirotani M, Niino M, Fukazawa T et al (2010) Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J Neuroimmunol 221:95-100
25. Li X, Zhong H, Bao W et al (2012) Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 120: 3318-3325
26. Hornung V, Rothenfusser S, Britsch S et al (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537
27. Jagannathan M, Hasturk H, Liang Y et al (2009) TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 183:7461-7470
28. Shin H, Zhang Y, Jagannathan M et al (2009) B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol 85: 648-655
29. Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M et al (2010) Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol 48:82-88
30. McDonnell M, Liang Y, Noronha A et al (2011) Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis 17: 298-307
31. Tsai JJ, Liu SH, Yin SC et al (2011) Mite allergen Der-p2 triggers human B lymphocyte activation and Toll-like receptor-4 induction. PLoS One 6:e23249
32. Das A, Ellis G, Pallant C et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189:3925-3935
33. Zhang M, Zheng X, Zhang J et al (2012) CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cell Immunol 274: 89-97
34. Agrawal S, Gupta S (2011) TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol 31:89-98
35. Correale J, Farez M (2009) Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol 183:5999-6012
36. van de Veen W, Stanic B, Yaman G et al (2013) IgG4 production is confi ned to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131:1204-1212
37. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176:705-710
38. Dilillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 1183:38-57
39. Fillatreau S, Gray D, Anderton SM (2008) Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 8:391-397
40. Hartmann G, Krieg AM (2000) Mechanism and function of a newly identifi ed CpG DNA motif in human primary B cells. J Immunol 164:944-953
41. Jiang W, Lederman MM, Harding CV et al (2007) TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 37: 2205-2213
42. Krieg AM, Yi AK, Matson S et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549
43. Barr TA, Shen P, Brown S et al (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209:1001-1010
44. Jin G, Hamaguchi Y, Matsushita T et al (2013) B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 131:1674-1682
45. Burdin N, Rousset F, Banchereau J (1997) B-cell-derived IL-10: production and function. Methods 11:98-111
46. Roederer M (2001) Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45:194-205
47. Herzenberg LA, Tung J, Moore WA et al (2006) Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7: 681-685
48. Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037-1042